Skip to content

Registry for Analysis of Quality of Life, Normal Organ Toxicity and Survival of Pediatric Patients Treated With Proton Therapy

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02644993
Enrollment
400
Registered
2016-01-01
Start date
2015-11-30
Completion date
Unknown
Last updated
2016-10-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pediatric Cancer Patients

Brief summary

The study aim of this study is to evaluate the effect of proton therapy on quality of life and long-term normal tissue toxicities of the pediatric cancer patients. Based on these results, the predictive model of long-term normal tissue toxicities, survival, and quality of life could be recognized. Risk-adapted treatment strategy based on the predictive model in pediatric cancer patients could be established.

Interventions

RADIATIONProton therapy

Sponsors

Samsung Medical Center
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
No minimum to 18 Years
Healthy volunteers
No

Inclusion criteria

* less than 18 years of age * patient who is planned to receive proton therapy at Samsung Medical Center * Informed consent

Exclusion criteria

* Refuse to participate this cohort study

Design outcomes

Primary

MeasureTime frame
Quality of Life Questionnairewithin 2 weeks before proton beam therapy

Secondary

MeasureTime frame
Quality of Life Questionnaire baselinewithin 1 week before proton beam therapy completion
Quality of Life Questionnaire3-6 months after proton beam therapy
Adverse event3-6 months after proton beam therapy

Countries

South Korea

Contacts

Primary ContactDo Hoon Lim, MD, PhD
dh8.lim@samsung.net82-2-3410-2612
Backup ContactJeong Il Yu, MD
ro.yuji651@gmail.com

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026